Rituximab Phase 2/3 Trial Fails to Meet Primary End Point in Primary Progressive MS Medscape Medical News, April 16, 200
This is a discussion on Rituximab Phase 2/3 Trial Fails to Meet Primary End Point in Primary Progressive MS Medscape Medical News, April 16, 200 within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; Japan Approves Roche's Drug Actemra for Arthritis Reuters Health Information, April 16, 2008 U.S. Must Do More to ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-17-2008, 02:58 AM
|
|||
|
|||
Rituximab Phase 2/3 Trial Fails to Meet Primary End Point in Primary Progressive MS Medscape Medical News, April 16, 200
Japan Approves Roche's Drug Actemra for Arthritis Reuters Health Information, April 16, 2008 U.S. Must Do More to Stem Hospital Infections: Report Reuters Health Information, April 16, 2008 CME Clinical Factors May Predict Survival in Extremely ...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Once-Daily Fluvoxamine Approved for Treatment of SAD and OCD Medscape Medical News, M | industry_news | Other Clinical Pharmacy News | 0 | 03-03-2008 11:43 AM |
| Effects of Ginkgo Biloba on Memory Still Not Clear Medscape Medical News, February 29 | industry_news | Other Clinical Pharmacy News | 0 | 02-29-2008 02:51 PM |
© 2008 DrugManagementForum™ powered by |
 |